JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 25, 2002; DOI: 10.1124/jpet.102.043471


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow All Versions of this Article:
jpet.102.043471v1
304/3/1299    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garnier, M.
Right arrow Articles by Scheideler, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garnier, M.
Right arrow Articles by Scheideler, M. A.

Vol. 304, Issue 3, 1299-1306, March 2003

Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine

Martine Garnier , Paola F. Zaratin , Giovanna Ficalora , Maurizio Valente , Laura Fontanella , Man-Hee Rhee, Kendall J. Blumer and Mark A. Scheideler

Department of Neurobiology Research, GlaxoSmithKline Pharmaceuticals, Milan, Italy (M.G., P.F.Z., G.F., M.V., L.F., M.A.S.); Neurology Centre of Excellence for Drug Discovery, New Frontiers Science Park, Harlow, Essex, United Kingdom (M.G., P.F.Z., G.F., M.V., L.F., M.A.S.); and Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri (M.-H.R., K.J.B.)

We hypothesized that the up-regulated expression of one or more members of the regulator of G protein signaling (RGS) family can cause an attenuation of signaling via Gi/Go-coupled opioid receptors, and thereby play a role in the development of hyperalgesia and accompanying insensitivity to morphine observed in animal models of neuropathic pain. Accordingly, we examined the mRNA expression of several RGS genes in a rat model of chronic neuropathic pain induced by partial ligation of the sciatic nerve. During the development of hyperalgesia, RGS4 was the only isoform examined whose mRNA levels increased significantly (up to 230%) in the lumbar spinal cord. In situ hybridization studies confirmed that RGS4 is present in the dorsal horn of the spinal cord where µ-opioid receptors (MORs) are also expressed. Overexpression of RGS4 in human embryonic kidney 293 cells stably expressing µ-opioid receptors predictably attenuated opioid agonist-induced inhibition of adenylyl cyclase. This inhibitory effect was overcome partially at high agonist concentrations, supporting the view that morphine insensitivity is promoted by RGS4 overexpression. These studies provide evidence that the up-regulation of RGS4 expression may contribute to changes in pain signal processing that lead to the development of hyperalgesia, and further affect its modulation by morphine.


0022-3565/03/3043-1299$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Wang, L.-Y. Liu-Chen, and J. R. Traynor
Differential Modulation of {micro}- and {delta}-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells
J. Biol. Chem., July 3, 2009; 284(27): 18357 - 18367.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. B. Penn and J. L. Benovic
Regulation of Heterotrimeric G Protein Signaling in Airway Smooth Muscle
Proceedings of the ATS, January 1, 2008; 5(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Jaen and C. A. Doupnik
RGS3 and RGS4 Differentially Associate with G Protein-coupled Receptor-Kir3 Channel Signaling Complexes Revealing Two Modes of RGS Modulation: PRECOUPLING AND COLLISION COUPLING
J. Biol. Chem., November 10, 2006; 281(45): 34549 - 34560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Grillet, A. Pattyn, C. Contet, B. L. Kieffer, C. Goridis, and J.-F. Brunet
Generation and Characterization of Rgs4 Mutant Mice
Mol. Cell. Biol., May 15, 2005; 25(10): 4221 - 4228.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G.-x. Xie and P. P. Palmer
RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms
Anesth. Analg., April 1, 2005; 100(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. F. Zaratin, G. Petrone, M. Sbacchi, M. Garnier, C. Fossati, P. Petrillo, S. Ronzoni, G. A. M. Giardina, and M. A. Scheideler

J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 454 - 461.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.